Most people in the UK are not getting enough vitamin D. That is not a supplement marketing line; it is the position of the NHS and the UK Health Security Agency, who advise that everyone should consider taking a vitamin D supplement during autumn and winter, and that higher-risk groups should supplement year-round.

Vitamin K2 is a different matter. It is increasingly paired with D3 in supplement formulations, and the rationale behind the combination is biologically sound. But the clinical evidence for K2 is at an earlier stage than for D3, and the marketing often runs ahead of what the research currently confirms.

This guide covers who genuinely benefits from D3 supplementation based on current UK guidance, what K2 adds to the picture, and where the evidence is solid versus where it is still developing.

Key takeaway: If you are in a higher-risk group for vitamin D deficiency, supplementing with D3 is well-supported. Adding K2 is a reasonable choice, particularly for bone and cardiovascular health, but it is not yet mandated by UK clinical guidelines.

Why Vitamin D Deficiency Is a UK-Specific Problem

The UK sits at a latitude where, between October and March, the sun's angle is too low for skin to synthesise vitamin D at all. Even in summer, cloud cover, indoor working patterns, and the use of sun protection limit how much most people actually produce.

The result is that vitamin D deficiency is genuinely common in the UK population, not a fringe concern. According to NHS clinical guidance, serum 25-hydroxyvitamin D levels below 25 nmol/L are classified as deficient, and levels between 25 and 50 nmol/L are considered insufficient. Adequate status is defined as above 50 nmol/L.

The problem: it is difficult to reach or maintain those levels through diet alone. Vitamin D is found in oily fish, egg yolks, red meat, and some fortified foods, but the quantities are modest. Supplementation is the practical solution for the majority of the UK population during winter, and for higher-risk groups throughout the year.

Why D3 Specifically?

Vitamin D comes in two supplemental forms: D2 (ergocalciferol) and D3 (cholecalciferol). NHS clinical guidance is clear on this point: colecalciferol (D3) is the preferred form because it raises serum vitamin D concentrations more effectively than D2. D3 is also the form the body produces naturally through sun exposure, making it the more physiologically relevant option.

Who Should Take Vitamin D3: The Higher-Risk Groups

The Department of Health and Social Care identifies specific groups who should supplement with 10 micrograms (400 IU) of vitamin D3 throughout the year, not just in winter. If you fall into any of the following categories, year-round supplementation is the recommended approach.

Risk Group

Why Deficiency Risk Is Higher

People with darker skin (African, African-Caribbean, South Asian heritage)

Melanin reduces the skin's ability to synthesise vitamin D from sunlight

Adults aged 65 and over

Skin becomes less efficient at producing vitamin D with age

Housebound individuals or care home residents

Minimal or no sun exposure throughout the year

People who cover most of their skin outdoors

Cultural dress or medical reasons limit UV exposure

Pregnant and breastfeeding women

Increased nutritional demands; breastfed infants rely on the mother's stores

People with obesity (BMI over 30)

Vitamin D is fat-soluble and can become sequestered in adipose tissue

People taking certain medications

Anti-epileptics, corticosteroids, and some other drugs can impair vitamin D metabolism

What About Everyone Else?

For people who do not fall into a higher-risk category, the NHS recommends considering a daily 10 mcg (400 IU) D3 supplement during autumn and winter (October to March). This is framed as a consideration rather than a mandate, because people with good sun exposure and a varied diet may maintain adequate levels through summer.

The practical reality is that most UK adults spend the majority of their working hours indoors. The NHS position that "everyone should consider" winter supplementation reflects this.

Worth noting: Routine blood testing for vitamin D is not recommended for asymptomatic people, even those in higher-risk groups. The clinical guidance is to supplement first, and only test if symptoms suggest deficiency (such as persistent musculoskeletal pain or proximal muscle weakness) or if there is a specific clinical indication.

Where Does Vitamin K2 Come In?

Vitamin K2 (menaquinone, most commonly in the MK-7 form) is increasingly paired with D3 in supplements, and the biological rationale is worth understanding rather than dismissing.

Here is the core mechanism: vitamin D3 promotes calcium absorption from the gut. That calcium needs to end up in bones, not in arterial walls. Vitamin K2 activates two key proteins that regulate where calcium goes:

  • Osteocalcin: a protein that binds calcium into bone matrix. K2 carboxylates (activates) it, directing calcium to where it is needed structurally.

  • Matrix Gla Protein (MGP): the body's most potent inhibitor of arterial calcification. K2 activates MGP, helping to prevent calcium from depositing in soft tissue and blood vessels.

The logic of combining D3 and K2 follows from this: increasing calcium absorption without adequate K2 activity could, in theory, leave calcium in circulation longer than ideal. Whether this translates into meaningful clinical risk at standard supplemental doses of D3 is debated, but the mechanism is biologically coherent.

What the Research Actually Shows

The evidence on K2 is promising but not yet definitive. A few important data points:

On bone health: A systematic review and meta-analysis published in Frontiers in Endocrinology (2025), covering nine randomised controlled trials with 2,570 participants, found that K2 supplementation improved key bone turnover biomarkers in postmenopausal women with osteoporosis. Osteocalcin carboxylation improved significantly. The authors noted that further long-term studies are needed to confirm whether these biomarker changes translate into measurable increases in bone mineral density.

On cardiovascular health: A three-year double-blind randomised trial in 244 healthy postmenopausal women found that daily MK-7 (180 mcg) inhibited age-related arterial stiffening compared to placebo. However, a separate randomised trial published in Circulation found that MK-7 plus vitamin D did not significantly reduce aortic valve calcification progression in elderly men with established calcification over two years, despite successfully reducing dp-ucMGP (the biomarker of K2 activity).

The honest interpretation: K2 clearly activates the right proteins. What is less clear is whether supplementing K2 at typical doses produces clinically meaningful outcomes in otherwise healthy people who are not already K2-deficient. The research is encouraging, particularly for older adults and postmenopausal women, but it is not at the same level of evidence as vitamin D3.

Who Has the Most to Gain from a D3 and K2 Combination

The case for combining D3 and K2 is strongest in specific contexts. This is not a supplement for everyone by default, but there are groups where the combination makes particular sense based on current evidence.

Postmenopausal Women

This is the group with the most research behind it. After the menopause, declining oestrogen accelerates bone loss and increases cardiovascular risk simultaneously. Both D3 and K2 address mechanisms relevant to these changes: D3 supports calcium absorption and bone mineralisation, while K2 activates osteocalcin for bone matrix and MGP for arterial protection. The 2025 meta-analysis and the three-year arterial stiffness trial both focused on this population specifically.

Adults Over 65

Older adults face a compound problem: reduced skin synthesis of vitamin D, reduced dietary variety, and lower levels of K2-activating activity. NHS guidance specifically recommends year-round D3 supplementation for this group. Adding K2 is a reasonable extension of that approach, particularly given the association between low vitamin K intake and cognitive decline observed in emerging research.

People Taking Higher-Dose Vitamin D3

At the standard 10 mcg (400 IU) dose, the theoretical concern about calcium misdirection is minimal. At higher doses (above 1,000 IU, which some people take on the advice of a GP or nutritionist following a deficiency diagnosis), the case for pairing with K2 becomes more relevant. The NHS upper safe limit for adults is 100 mcg (4,000 IU) daily; doses in the 1,000 to 4,000 IU range are sometimes used in maintenance protocols following treatment for confirmed deficiency.

People with Low Dietary K2 Intake

K2 is found primarily in fermented foods (particularly natto, a Japanese fermented soybean product), aged cheeses, and some animal products. It is largely absent from typical Western diets. People eating a low-fat, low-animal-product, or vegan diet are more likely to have suboptimal K2 intake and may benefit more from supplementation.

Who Probably Does Not Need to Prioritise K2

  • Healthy adults under 40 with no specific bone or cardiovascular risk factors

  • People whose primary concern is correcting a straightforward vitamin D deficiency

  • Anyone who has not yet addressed their D3 status, for whom K2 is a secondary consideration

The priority is always to address vitamin D first. K2 is a sensible addition, not the foundation.

Dosage Context: What UK Guidance Actually Recommends

Understanding the dosage landscape helps cut through the noise, because supplement products vary considerably, and the numbers can be confusing.

Vitamin D3

Situation

Recommended Dose

Notes

General winter supplementation (all adults)

10 mcg / 400 IU daily

NHS recommendation, October to March

Year-round supplementation (higher-risk groups)

10 mcg / 400 IU daily

Recommended throughout the year

Maintenance following confirmed deficiency

20–50 mcg / 800–2,000 IU daily

As directed, OTC purchase recommended

Upper safe limit (adults)

100 mcg / 4,000 IU daily

Do not exceed without medical supervision

The NHS is explicit: do not take more than 100 mcg (4,000 IU) per day without clinical oversight, as excessive vitamin D can cause hypercalcaemia (raised blood calcium), which carries its own risks.

Vitamin K2

There is no established UK recommended daily intake for K2 specifically. Clinical trials have used doses ranging from 90 to 180 mcg of MK-7 daily. The MK-7 form (menaquinone-7) is preferred in supplementation because of its longer half-life compared to MK-4, meaning it remains active in the body for longer.

One important caution: vitamin K2 can interact with anticoagulant medications, particularly warfarin. Anyone taking blood-thinning medication should consult their GP before adding K2 to their routine.

Frequently Asked Questions

Do I need to take K2 with D3?

Not necessarily. At the standard 400 IU dose of D3, there is no clinical requirement to take K2 alongside it. The combination is most relevant for people taking higher doses of D3, older adults, postmenopausal women, or anyone with specific bone or cardiovascular health concerns. For most people, correcting a straightforward winter deficiency, D3 alone is sufficient.

Can I get enough vitamin D from food in the UK?

Unlikely, for most people. Dietary sources of vitamin D (oily fish, egg yolks, fortified cereals) provide modest amounts. The NHS acknowledges that meeting the 400 IU daily recommendation through food alone is difficult, which is why supplementation is recommended.

Should I get a blood test before supplementing?

The NHS does not recommend routine testing for asymptomatic people. If you fall into a higher-risk group, the guidance is to supplement without testing. Testing is recommended if you have symptoms that could indicate a deficiency (persistent bone or muscle pain, weakness) or if you have a condition that affects vitamin D metabolism.

Is it safe to take D3 and K2 together?

Yes, for most people. Both are fat-soluble vitamins and are best taken with a meal containing some fat to aid absorption. The combination is well-tolerated in clinical trials. The main exception is K2 for anyone on anticoagulant medication, where GP advice should be sought first.

What form of K2 should I look for?

MK-7 (menaquinone-7) is the preferred form for supplementation. It has a significantly longer half-life than MK-4, which means a single daily dose maintains activity throughout the day. Look for this specified on the label.

The Bottom Line

Vitamin D3 supplementation in the UK is not a wellness trend. It is a response to a genuine gap between the vitamin D most people can realistically obtain from sun exposure and diet, and the levels needed for normal bone, muscle, and immune function. If you are in a higher-risk group, the evidence and the NHS guidance are aligned: supplement year-round.

Vitamin K2 is a more nuanced addition. The mechanism is sound, the early research is encouraging, and the combination is well-tolerated. For postmenopausal women, adults over 65, and people taking higher-dose D3, adding K2 (as MK-7) is a reasonable, evidence-informed choice. For everyone else, it is a sensible extra, not an urgent priority.

The practical starting point: address your vitamin D status first. If you are in a higher-risk group or it is winter, start with 10 mcg (400 IU) of D3 daily. Then consider whether the addition of K2 makes sense for your specific situation.

This article is for informational purposes only and does not constitute medical advice. If you have a health condition or take prescription medication, consult your GP before starting any new supplement.

Latest Stories

This section doesn’t currently include any content. Add content to this section using the sidebar.